DYCLONE Drug Patent Profile
✉ Email this page to a colleague
When do Dyclone patents expire, and when can generic versions of Dyclone launch?
Dyclone is a drug marketed by Astrazeneca and is included in one NDA.
The generic ingredient in DYCLONE is dyclonine hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dyclonine hydrochloride profile page.
Summary for DYCLONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Patent Applications: | 595 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DYCLONE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DYCLONE
US Patents and Regulatory Information for DYCLONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | DYCLONE | dyclonine hydrochloride | SOLUTION;TOPICAL | 009925-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astrazeneca | DYCLONE | dyclonine hydrochloride | SOLUTION;TOPICAL | 009925-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |